Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin versus trospium chloride versus placebo for neurogenic bladder after stroke
IRCT20160606028304N2Phase 4Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in neurogenic bladder comparing Solifenacin, Trospium chloride and Placebo (3 arms). Primary endpoints: NBSS score, ICIQ-SF score and 1 more. Started Jul 2021; status: completed.
02
Drugs
solifenacintrospium
03
Conditions
neurogenic bladder
Beyond the preview
Go deeper on IRCT20160606028304N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160606028304N2.